Tumor response evaluation in oncology: current update

Journal of Computer Assisted Tomography
Alampady Krishna Prasad ShanbhogueSrinivasa R Prasad

Abstract

Quantification of tumor burden and assessment of changes in tumor size after chemotherapy are commonly performed to evaluate treatment response in oncology trials. Validation and adoption of different criteria have been attempted in the past to achieve uniformity in scanning techniques and measurement metrics so that comparison of different oncological trials is feasible. Response assessment of solid tumors is usually consisted of either bidimensional (World Health Organization criteria) or unidimensional (Response Evaluation Criteria in Solid Tumors [RECIST] guidelines) measurement of tumors before and after chemotherapy. RECIST 1.1 criteria have been recently published. In this article, we try to provide a comprehensive review of the tumor response evaluation guidelines that were recently updated in attempts to overcome limitations of the previous criteria as well as incorporate recent advances in imaging techniques.

References

Sep 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D WarrI Tannock
Jan 1, 1981·Cancer·A B MillerA Winkler
Apr 1, 1993·AJR. American Journal of Roentgenology·B A UrbanS S Siegelman
Jan 1, 1997·Journal of Magnetic Resonance Imaging : JMRI·R BraschO Melnyk
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L BlumT Griffin
Mar 24, 1999·Journal of the National Cancer Institute·K JamesP Therasse
Feb 7, 2001·Radiology·K D HopperA Finkel
Feb 13, 2001·AJR. American Journal of Roentgenology·S Saini
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 29, 2004·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Heike E Daldrup-LinkRobert C Brasch
Apr 18, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P TherasseJ Verweij
Aug 26, 2006·European Journal of Radiology·Tristan BarrettPeter L Choyke
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Jul 12, 2007·Journal of Magnetic Resonance Imaging : JMRI·Tristan BarrettPeter L Choyke
Mar 12, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Khaled M ElsayesJeffrey J Brown
Mar 20, 2008·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Chikako SuzukiLennart Blomqvist
Jun 17, 2008·The Oncologist·Haesun Choi
May 15, 2008·Journal of the National Cancer Institute·Josep M LlovetUNKNOWN Panel of Experts in HCC-Design Clinical Trials
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Dec 20, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jan BogaertsUNKNOWN RECIST Working Party
Dec 20, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Chaya S MoskowitzMithat Gönen
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
May 2, 2009·Magnetic Resonance Imaging Clinics of North America·Colm J McMahonNeil M Rofsky

❮ Previous
Next ❯

Citations

Jun 13, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rajul K JainRazelle Kurzrock
Jun 26, 2013·AJR. American Journal of Roentgenology·Vahid YaghmaiBachir Taouli
May 9, 2012·Medical Physics·Zachary H LevineClaus P Heussel
Nov 16, 2013·La Radiologia medica·Gianpaolo CarrafielloCarlo Fugazzola
Jan 23, 2016·Gastroenterology Research and Practice·Daniel MarinFrancesco Somma
Nov 22, 2015·Technology in Cancer Research & Treatment·David C P CobbenAstrid L H M W van Lier
Feb 26, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lin GongZhi-Lan Peng
Mar 1, 2012·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·Amy K LeblancFederica Morandi
Mar 31, 2017·Molecular and Clinical Oncology·Yongping LiuChangsong Zhang
Dec 20, 2012·Expert Review of Vaccines·Sofie Denies, Niek N Sanders
Dec 3, 2016·Medical Oncology·Anna Maria IerardiGianpaolo Carrafiello
Jul 6, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·L Leon-MateosL Gorospe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
R Temple
Radiographics : a Review Publication of the Radiological Society of North America, Inc
Roberto García FigueirasPeter L Choyke
Clinics in Dermatology
Claus Garbe, Ulrike Leiter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Charles M BalchVernon K Sondak
© 2021 Meta ULC. All rights reserved